HSIC · Henry Schein Inc
$85.72
+0.55 (+0.65%)
At close · Jul 31
Market Cap
$9.70B
Shares
113.92M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$13.18B
+4%
FY2025
Net Income
$398M
+2.1%
FY2025
Gross Margin
31.14%
-0.6pp
FY2025
Operating Margin
4.95%
0pp
FY2025
Diluted EPS
$3.27
+7.2%
FY2025
Operating Cash Flow
$712M
-16%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $13.38B | $13.18B | $12.67B | $12.34B | $12.65B | $12.4B | $10.12B | $9.99B | $13.2B | $12.46B | $11.57B | $10.63B | $10.37B | $9.56B | $8.94B | $8.53B | — | — | — | |
| — | $9.21B | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.3B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | $7.46B | $6.9B | $6.43B | $6.11B | $5.36B | $4.62B | $4.51B | |
| — | $4.18B | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | $2.91B | $2.66B | $2.51B | $2.42B | $2.17B | $1.92B | $1.87B | |
| — | — | 31.14% | 31.69% | 31.28% | 30.29% | 29.63% | 27.83% | 30.95% | 22.05% | 22.04% | 27.88% | 28.29% | 28.07% | 27.78% | 28.05% | 28.35% | — | — | — | |
| — | $3.16B | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | $2.2B | $1.98B | $1.87B | $1.84B | $1.64B | $1.45B | $1.43B | |
| — | — | $180M | $185M | $152M | $126M | $124M | $106M | $108.3M | $75.3M | $70.3M | $98.2M | $92.9M | $89.6M | $69.2M | $68.5M | $58.8M | $48.4M | — | — | |
| — | $319M | $311M | $297M | $248M | $212M | $210M | $186M | $184.94M | $143.63M | $133.86M | $169.78M | $159.13M | $152.24M | $128.04M | $125.32M | $115.9M | $101.21M | $81.49M | $78.13M | |
| — | $92M | $105M | $110M | $80M | $128M | $8M | — | — | $54.37M | $0 | $45.89M | $34.93M | $0 | $0 | $15.19M | $0 | $12.29M | $3.02M | $23.24M | |
| — | — | — | — | — | — | — | — | — | $2.7B | $2.53B | $2.41B | — | — | — | — | — | — | — | — | |
| — | $660M | $653M | $621M | $615M | $747M | $852M | $535M | $718.26M | $600.62M | $669.76M | $771.57M | $733.97M | $715.14M | $677.05M | $618.96M | $582.15M | $521.13M | $464.09M | $419.29M | |
| — | — | 4.95% | 4.9% | 4.98% | 5.91% | 6.87% | 5.29% | 7.19% | 4.55% | 5.37% | 6.67% | 6.9% | 6.9% | 7.08% | 6.92% | 6.82% | — | — | — | |
| — | $979M | $964M | $918M | $863M | $959M | $1.06B | $721M | $903.2M | $744.25M | $803.62M | $941.35M | $893.1M | $867.38M | $805.09M | $744.28M | $698.05M | $622.35M | $545.58M | $497.41M | |
| — | $154M | $150M | $131M | $87M | $35M | $27M | $41M | $50.79M | $76.02M | $51.07M | $31.89M | $26.01M | $24.06M | $27.54M | $30.9M | $30.38M | $33.64M | $23.37M | $34.61M | |
| — | $34M | $33M | $24M | $17M | $8M | $6M | $10M | $15.76M | $15.49M | $12.44M | $13.28M | $12.94M | $13.66M | $12.85M | $13.39M | $15.59M | $14.1M | $9.98M | $16.36M | |
| — | -$2M | -$3M | -$1M | -$3M | $1M | $0 | -$4M | -$2.92M | -$3.26M | -$1.34M | $2.88M | -$141K | $4.57M | $2.33M | $2.74M | $1.94M | $447K | $2.03M | -$5.59M | |
| — | $9M | $12M | $13M | $14M | $15M | $20M | $12M | $17.9M | $21.04M | $15.29M | $18.52M | $14.06M | $11.73M | $10.19M | $7.06M | $15.56M | $10.17M | $5.24M | $5.04M | |
| — | $538M | $533M | $513M | $542M | $721M | $831M | $500M | $680.31M | $536.84M | $629.79M | $755.84M | $720.76M | $709.31M | $664.69M | $604.19M | $569.31M | $502.04M | $452.72M | $395.45M | |
| — | $129M | $126M | $128M | $120M | $170M | $198M | $95M | $159.52M | $107.43M | $308.98M | $217.96M | $211.39M | $215.61M | $190.89M | $187.86M | $180.21M | $160.07M | $127.52M | $131.21M | |
| — | $395M | $398M | $390M | $416M | $538M | $631M | $404M | $694.73M | $535.88M | $406.3M | $506.78M | $479.06M | $466.08M | $431.55M | $388.08M | $367.66M | $325.79M | $311.15M | $239.46M | |
| — | — | 3.02% | 3.08% | 3.37% | 4.25% | 5.09% | 3.99% | 6.96% | 4.06% | 3.26% | 4.38% | 4.51% | 4.49% | 4.51% | 4.34% | 4.31% | — | — | — | |
| — | $23M | $21M | $8M | $20M | $28M | $29M | $16M | $24.4M | $26.25M | $52.99M | $49.62M | $44.37M | $39.36M | $39.91M | $35.31M | $37M | $26.34M | $22M | $21.92M | |
| — | $523M | $551M | $217M | $443M | $476M | $568M | $463M | $682.72M | $417.18M | $593.27M | $409.68M | $354.25M | $303.1M | $446.55M | $418.35M | $359.73M | $292.11M | $345.63M | $168.91M | |
| USD/shares | — | — | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | $5.53 | $5.02 | $4.44 | $4.08 | $3.62 | $3.50 | $2.69 |
| USD/shares | $5.23 – $5.37* | — | $3.27 | $3.05G | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | $5.44 | $4.93 | $4.32 | $3.97 | $3.49 | $3.44 | $2.63 |
| shares | — | — | 120.81M | 126.79M | 130.62M | 136.06M | 140.09M | 142.5M | 147.82M | 152.66M | 156.79M | 161.64M | 165.69M | 84.27M | 85.93M | 87.5M | 90.12M | 90.1M | 88.87M | 89.08M |
| shares | — | — | 121.72M | 127.78M | 131.75M | 137.76M | 141.77M | 143.4M | 149.26M | 153.71M | 158.21M | 163.72M | 168.25M | 85.74M | 87.62M | 89.82M | 92.62M | 93.27M | 90.56M | 91.22M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $5.71B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
25.73×
Medical Distribution median 23.87×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Global Distribution and Value Added Services | $11,138,000,000 | $10,760,000,000 | $10,561,000,000 | $10,975,000,000 | — | — | — | — |
| Global Specialty Products | $1,544,000,000 | $1,446,000,000 | $1,331,000,000 | $1,273,000,000 | — | — | — | — |
| Global Technology | $675,000,000 | $630,000,000 | $602,000,000 | $549,000,000 | — | — | — | — |
| Corporate TSA | — | — | — | $0 | — | $75,000,000 | $81,267,000 | $0 |
| Healthcare Distribution | — | — | $11,533,000,000 | $11,924,000,000 | $11,754,000,000 | $9,530,000,000 | $9,389,451,000 | $9,009,164,000 |
| Technology | — | — | $806,000,000 | $723,000,000 | $647,000,000 | $514,000,000 | $515,085,000 | $408,439,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $9,096,000,000 | $8,825,000,000 | $8,662,000,000 | $9,197,000,000 | $8,722,000,000 | $7,090,000,000 | $6,876,194,000 | $6,411,558,000 |
| Non Us | $4,088,000,000 | $3,848,000,000 | $3,677,000,000 | — | — | — | — | — |
| Locations Other Than United States | — | — | — | $3,450,000,000 | $3,679,000,000 | $3,029,000,000 | $3,109,609,000 | $3,006,045,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Global Distribution and Value Added Services | $680,000,000 | $696,000,000 | $665,000,000 | $833,000,000 | — | — | — | — |
| Global Specialty Products | $242,000,000 | $178,000,000 | $175,000,000 | $192,000,000 | — | — | — | — |
| Global Technology | $180,000,000 | $152,000,000 | $142,000,000 | $125,000,000 | — | — | — | — |
| Healthcare Distribution | — | — | $470,000,000 | $619,000,000 | $727,000,000 | $436,000,000 | $591,404,000 | $490,988,000 |
| Technology | — | — | $145,000,000 | $128,000,000 | $125,000,000 | $99,000,000 | $126,857,000 | $109,631,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Global Distribution and Value Added Services | 6.1% | 6.5% | 6.3% | 7.6% | — | — | — | — |
| Global Specialty Products | 15.7% | 12.3% | 13.1% | 15.1% | — | — | — | — |
| Global Technology | 26.7% | 24.1% | 23.6% | 22.8% | — | — | — | — |
| Healthcare Distribution | — | — | 4.1% | 5.2% | 6.2% | 4.6% | 6.3% | 5.4% |
| Technology | — | — | 18% | 17.7% | 19.3% | 19.3% | 24.6% | 26.8% |
Key facts
CIK
1000228
CUSIP
806407102
13F (30d)
191 filings
166 filers
Visit website
Investor relations